Risk for subsequent coronary artery disease after preeclampsia.
暂无分享,去创建一个
[1] A. Quyyumi,et al. Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.
[2] N. Sattar,et al. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? , 2002, BMJ : British Medical Journal.
[3] James M. Roberts,et al. Contemporary concepts of the pathogenesis and management of preeclampsia. , 2002, JAMA.
[4] J. Kooner,et al. Association of maternal endothelial dysfunction with preeclampsia. , 2001, JAMA.
[5] Jm Roberts,et al. Pathogenesis and genetics of pre-eclampsia , 2001, The Lancet.
[6] H. Laivuori,et al. Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. , 1999, Obstetrics and gynecology.
[7] I. Sargent,et al. Preeclampsia: an excessive maternal inflammatory response to pregnancy. , 1999, American journal of obstetrics and gynecology.
[8] S. Ferry,et al. Cardiovascular sequelae of toxaemia of pregnancy. , 1997, Heart.
[9] L H Kuller,et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. , 1995, Annals of epidemiology.
[10] Lippincott Williams Wilkins,et al. National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes , 1994, Hypertension.
[11] A. Saftlas,et al. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. , 1990, American journal of obstetrics and gynecology.
[12] P. Ganz,et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.
[13] R. Ness,et al. Homocysteine and cellular fibronectin are increased in preeclampsia, not transient hypertension of pregnancy. , 2001, Hypertension in pregnancy.